Cargando…
Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation
Telomeres are repetitive DNA sequences that protect the ends of linear chromosomes, and they are maintained by a ribonucleoprotein complex called telomerase. Variants in genes encoding for telomerase components have been associated with a spectrum of disease in the lung, skin, bone marrow, and liver...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594079/ https://www.ncbi.nlm.nih.gov/pubmed/30964210 http://dx.doi.org/10.1002/hep.30557 |
_version_ | 1783430184500723712 |
---|---|
author | Chiu, Victor Hogen, Rachel Sher, Linda Wadé, Niquelle Conti, David Martynova, Anastasia Li, Hongtao Liang, Gangning O'Connell, Casey |
author_facet | Chiu, Victor Hogen, Rachel Sher, Linda Wadé, Niquelle Conti, David Martynova, Anastasia Li, Hongtao Liang, Gangning O'Connell, Casey |
author_sort | Chiu, Victor |
collection | PubMed |
description | Telomeres are repetitive DNA sequences that protect the ends of linear chromosomes, and they are maintained by a ribonucleoprotein complex called telomerase. Variants in genes encoding for telomerase components have been associated with a spectrum of disease in the lung, skin, bone marrow, and liver. Mutations in the telomerase reverse transcriptase and telomerase RNA component genes have been observed at a higher prevalence in patients with liver disease compared with the general population; however, the presence of variants in other components of the telomerase complex and their impact on clinical outcomes has not been explored. We evaluated 86 patients with end‐stage liver disease for variants in an expanded panel of eight genes, and found that 17 patients (20%) had likely deleterious variants by in silico analysis. Seven unique likely deleterious variants were identified in the regulator of telomere elongation helicase 1 (RTEL1) gene that encodes for a DNA helicase important in telomere maintenance and genomic stability. In gene burden association analysis of their clinical data, the presence of any RTEL1 variant was associated with a 29% lower baseline white blood cell count (95% confidence interval [CI], ‐7% to ‐46%; P Value = 0.01) compared with patients without RTEL1 variants, and the presence of any exonic missense RTEL1 variant was associated with a 42% lower baseline platelet count (95% CI, ‐5% to ‐65%: P Value = 0.03). The presence of any telomerase variant was associated with an increased number of readmissions within 1 year after transplantation demonstrated by an incident rate ratio (IRR) of 3.15 (95% CI, 1.22 to 8.57). No association with survival was observed. Conclusion: Among patients who underwent liver transplantation, the presence of any exonic missense variant was associated with a longer postoperative length of stay with an IRR of 2.16 (95% CI, 1.31 to 3.68). |
format | Online Article Text |
id | pubmed-6594079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65940792019-07-10 Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation Chiu, Victor Hogen, Rachel Sher, Linda Wadé, Niquelle Conti, David Martynova, Anastasia Li, Hongtao Liang, Gangning O'Connell, Casey Hepatology Original Articles Telomeres are repetitive DNA sequences that protect the ends of linear chromosomes, and they are maintained by a ribonucleoprotein complex called telomerase. Variants in genes encoding for telomerase components have been associated with a spectrum of disease in the lung, skin, bone marrow, and liver. Mutations in the telomerase reverse transcriptase and telomerase RNA component genes have been observed at a higher prevalence in patients with liver disease compared with the general population; however, the presence of variants in other components of the telomerase complex and their impact on clinical outcomes has not been explored. We evaluated 86 patients with end‐stage liver disease for variants in an expanded panel of eight genes, and found that 17 patients (20%) had likely deleterious variants by in silico analysis. Seven unique likely deleterious variants were identified in the regulator of telomere elongation helicase 1 (RTEL1) gene that encodes for a DNA helicase important in telomere maintenance and genomic stability. In gene burden association analysis of their clinical data, the presence of any RTEL1 variant was associated with a 29% lower baseline white blood cell count (95% confidence interval [CI], ‐7% to ‐46%; P Value = 0.01) compared with patients without RTEL1 variants, and the presence of any exonic missense RTEL1 variant was associated with a 42% lower baseline platelet count (95% CI, ‐5% to ‐65%: P Value = 0.03). The presence of any telomerase variant was associated with an increased number of readmissions within 1 year after transplantation demonstrated by an incident rate ratio (IRR) of 3.15 (95% CI, 1.22 to 8.57). No association with survival was observed. Conclusion: Among patients who underwent liver transplantation, the presence of any exonic missense variant was associated with a longer postoperative length of stay with an IRR of 2.16 (95% CI, 1.31 to 3.68). John Wiley and Sons Inc. 2019-04-09 2019-06 /pmc/articles/PMC6594079/ /pubmed/30964210 http://dx.doi.org/10.1002/hep.30557 Text en © 2019 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Chiu, Victor Hogen, Rachel Sher, Linda Wadé, Niquelle Conti, David Martynova, Anastasia Li, Hongtao Liang, Gangning O'Connell, Casey Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation |
title | Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation |
title_full | Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation |
title_fullStr | Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation |
title_full_unstemmed | Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation |
title_short | Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation |
title_sort | telomerase variants in patients with cirrhosis awaiting liver transplantation |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594079/ https://www.ncbi.nlm.nih.gov/pubmed/30964210 http://dx.doi.org/10.1002/hep.30557 |
work_keys_str_mv | AT chiuvictor telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT hogenrachel telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT sherlinda telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT wadeniquelle telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT contidavid telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT martynovaanastasia telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT lihongtao telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT lianggangning telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation AT oconnellcasey telomerasevariantsinpatientswithcirrhosisawaitinglivertransplantation |